Henry A Dunn, Cornelia Walther, Christina M Godin, Randy A Hall, Stephen S G Ferguson
Index: J. Biol. Chem. 288(21) , 15023-34, (2013)
Full Text: HTML
The corticotropin-releasing factor (CRF) receptor 1 (CRFR1) is a target for the treatment of psychiatric diseases such as depression, schizophrenia, anxiety disorder, and bipolar disorder. The carboxyl-terminal tail of the CRFR1 terminates in a PDZ-binding motif that provides a potential site for the interaction of PSD-95/Discs Large/Zona Occludens 1 (PDZ) domain-containing proteins. In this study, we found that CRFR1 interacts with synapse-associated protein 97 (SAP97; also known as DLG1) by co-immunoprecipitation in human embryonic 293 (HEK 293) cells and cortical brain lysates and that this interaction is dependent upon an intact PDZ-binding motif at the end of the CRFR1 carboxyl-terminal tail. Similarly, we demonstrated that SAP97 is recruited to the plasma membrane in HEK 293 cells expressing CRFR1 and that mutation of the CRFR1 PDZ-binding motif results in the redistribution of SAP97 into the cytoplasm. Overexpression of SAP97 antagonized agonist-stimulated CRFR1 internalization, whereas single hairpin (shRNA) knockdown of endogenous SAP97 in HEK 293 cells resulted in increased agonist-stimulated CRFR1 endocytosis. CRFR1 was internalized as a complex with SAP97 resulting in the redistribution of SAP97 to endocytic vesicles. Overexpression or shRNA knockdown of SAP97 did not significantly affect CRFR1-mediated cAMP formation, but SAP97 knockdown did significantly attenuate CRFR1-stimulated ERK1/2 phosphorylation in a PDZ interaction-independent manner. Taken together, our studies show that SAP97 interactions with CRFR1 attenuate CRFR1 endocytosis and that SAP97 is involved in coupling G protein-coupled receptors to the activation of the ERK1/2 signaling pathway.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Guanylate Kinase
CAS:9026-59-9 |
|
Initial characterization of the human central proteome.
2011-01-01 [BMC Syst. Biol. 5 , 17, (2011)] |
|
Complete sequencing and characterization of 21,243 full-leng...
2004-01-01 [Nat. Genet. 36 , 40-5, (2004)] |
|
The status, quality, and expansion of the NIH full-length cD...
2004-10-01 [Genome Res. 14 , 2121-7, (2004)] |
|
Lys-N and trypsin cover complementary parts of the phosphopr...
2009-06-01 [Anal. Chem. 81(11) , 4493-501, (2009)] |
|
Tau-mediated NMDA receptor impairment underlies dysfunction ...
2014-12-03 [J. Neurosci. 34(49) , 16482-95, (2014)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
